Hemostemix Stock Buy Hold or Sell Recommendation
| HEM Stock | CAD 0.07 0.01 7.14% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Hemostemix is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Hemostemix given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Hemostemix, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Hemostemix Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Hemostemix and provide practical buy, sell, or hold advice based on investors' constraints. Hemostemix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Hemostemix |
Execute Hemostemix Buy or Sell Advice
The Hemostemix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Hemostemix. Macroaxis does not own or have any residual interests in Hemostemix or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Hemostemix's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Hemostemix Trading Alerts and Improvement Suggestions
| Hemostemix had very high historical volatility over the last 90 days | |
| Hemostemix has some characteristics of a very speculative penny stock | |
| Hemostemix has high likelihood to experience some financial distress in the next 2 years | |
| Hemostemix has accumulated 4.32 M in total debt. Hemostemix has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Hemostemix until it has trouble settling it off, either with new capital or with free cash flow. So, Hemostemix's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hemostemix sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hemostemix to invest in growth at high rates of return. When we think about Hemostemix's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (2.5 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hemostemix has accumulated about 49.36 K in cash with (1.5 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Hemostemix Secures 2.73M in Expanded Private Placement Offering with Insider Participation HMTXF Stock News - StockTitan |
Hemostemix Returns Distribution Density
The distribution of Hemostemix's historical returns is an attempt to chart the uncertainty of Hemostemix's future price movements. The chart of the probability distribution of Hemostemix daily returns describes the distribution of returns around its average expected value. We use Hemostemix price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Hemostemix returns is essential to provide solid investment advice for Hemostemix.
| Mean Return | 0.23 | Value At Risk | -15 | Potential Upside | 12.50 | Standard Deviation | 10.17 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Hemostemix historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Hemostemix Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (1.4M) | 233.9K | (38.5K) | (83.7K) | 19.7K | 20.7K | |
| Free Cash Flow | (3.4M) | (6.0M) | (3.5M) | (6.1M) | (1.5M) | (1.6M) | |
| Other Non Cash Items | 105.0K | 106.0K | (114.3K) | 172.8K | 335.9K | 352.7K | |
| Net Income | (4.9M) | (7.8M) | (6.3M) | (5.2M) | (2.5M) | (2.6M) | |
| End Period Cash Flow | 24.1K | 258.0K | 219.4K | 135.7K | 155.4K | 147.6K | |
| Change To Netincome | 1.6M | 438.2K | 2.6M | 838.4K | 964.1K | 1.0M |
Hemostemix Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Hemostemix or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Hemostemix's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Hemostemix stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.25 | |
β | Beta against Dow Jones | -0.55 | |
σ | Overall volatility | 10.31 | |
Ir | Information ratio | 0.02 |
Hemostemix Volatility Alert
Hemostemix is showing large volatility of returns over the selected time horizon. Hemostemix is a penny stock. Although Hemostemix may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Hemostemix. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Hemostemix instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Hemostemix Fundamentals Vs Peers
Comparing Hemostemix's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Hemostemix's direct or indirect competition across all of the common fundamentals between Hemostemix and the related equities. This way, we can detect undervalued stocks with similar characteristics as Hemostemix or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Hemostemix's fundamental indicators could also be used in its relative valuation, which is a method of valuing Hemostemix by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Hemostemix to competition |
| Fundamentals | Hemostemix | Peer Average |
| Return On Asset | -3.49 | -0.14 |
| Current Valuation | 14.56 M | 16.62 B |
| Shares Outstanding | 140.64 M | 571.82 M |
| Shares Owned By Insiders | 9.54 % | 10.09 % |
| Number Of Shares Shorted | 11.93 K | 4.71 M |
| Price To Earning | (1.70) X | 28.72 X |
| Price To Book | 27.76 X | 9.51 X |
| EBITDA | (2.16 M) | 3.9 B |
| Net Income | (2.5 M) | 570.98 M |
| Cash And Equivalents | 49.36 K | 2.7 B |
| Total Debt | 4.32 M | 5.32 B |
| Current Ratio | 0.05 X | 2.16 X |
| Book Value Per Share | (0.09) X | 1.93 K |
| Cash Flow From Operations | (1.5 M) | 971.22 M |
| Short Ratio | 0.17 X | 4.00 X |
| Earnings Per Share | (0.03) X | 3.12 X |
| Target Price | 0.96 | |
| Beta | 0.19 | -0.15 |
| Market Capitalization | 10.55 M | 19.03 B |
| Total Asset | 313.76 K | 29.47 B |
| Retained Earnings | (63.27 M) | 9.33 B |
| Working Capital | (2.56 M) | 1.48 B |
| Net Asset | 313.76 K |
Hemostemix Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Hemostemix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Hemostemix Buy or Sell Advice
When is the right time to buy or sell Hemostemix? Buying financial instruments such as Hemostemix Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Hemostemix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Companies that provide healthcare goods and services including hospitals, health maintenance organizations, HMOs, or medical aid manufacturers. The Healthcare theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Hemostemix Stock Analysis
When running Hemostemix's price analysis, check to measure Hemostemix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemostemix is operating at the current time. Most of Hemostemix's value examination focuses on studying past and present price action to predict the probability of Hemostemix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemostemix's price. Additionally, you may evaluate how the addition of Hemostemix to your portfolios can decrease your overall portfolio volatility.